Intralesional Triamcinolone for Fistulous Tracts in Hidradenitis Suppurativa: An Uncontrolled Prospective Trial with Clinical and Ultrasonographic Follow-Up.
Por:
Alvarez, P, Garcia-Martinez, F, Poveda, I and Pascual, J
Publicada:
29 may 2019
Ahead of Print:
29 may 2019
Resumen:
There is little evidence on the use of intralesional triamcinolone (ILT) for managing fistulous tracts in hidradenitis suppurativa (HS).
Filiaciones:
:
Department of Dermatology, University General Hospital of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
Garcia-Martinez, F:
Department of Dermatology, Clínica Universidad de Navarra, Madrid, Spain
:
Department of Dermatology, University General Hospital of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain
:
Department of Dermatology, University General Hospital of Alicante, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain,
|